Insider · CIK 0001242613
Timothy M Mayleben
Files at MRNS (MARINUS PHARMACEUTICALS, INC.). First filing -, latest -.
In brief
Timothy M Mayleben files SEC Form 4 as director at MRNS (MARINUS PHARMACEUTICALS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Timothy M Mayleben has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 10, 2024 | MRNS MARINUS PHARMACEUTICALS, INC. | GGift Common Stockindirect: By Trust | -4,980 | $0.00 | $0 | 13,957 | Oct 15, 2024 |
| Oct 10, 2024 | MRNS MARINUS PHARMACEUTICALS, INC. | GGift Common Stockindirect: By Trust | -1,660 | $0.00 | $0 | 12,297 | Oct 15, 2024 |
| Oct 10, 2024 | MRNS MARINUS PHARMACEUTICALS, INC. | GGift Common Stockindirect: By Trust | -1,660 | $0.00 | $0 | 10,637 | Oct 15, 2024 |
Questions about Timothy M Mayleben
Answered from the filings on this page, as of the latest one.
Is Timothy M Mayleben buying or selling?
Timothy M Mayleben has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Timothy M Mayleben's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Timothy M Mayleben has 0.
Where does Timothy M Mayleben file Form 4?
Timothy M Mayleben has filed Form 4 at MRNS (MARINUS PHARMACEUTICALS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.